or
Remember me
Back
ALST has formed a strategic partnership with Virotek Biosciences Inc., to facilitate the application of the rapid COVID test to the various AllStar commercial, industrial and civic customers. Agreeing to regular testing appears to be one of the alternatives that some employers will accept in place of double dose vaccine. This opens the way for services such as the ALST- Virotek partnership to complete those tests.
The Company has also entered into the testing phase of the new web site https://vividcbd.com/. We have secured a contracted supply of the product, we have the rights to expand into other product lines, and we have the systems in place to start taking orders over the next few days.
“All of our efforts to bring to market different services and different product offerings are about to start paying off,” said Pete Wanner, CEO of ALST. “Our sales pipelines are eager to have these services and products become available to them and we anticipate a rapid acceptance of these new products from our existing clients.” https://www.globenewswire.com/news-release/2021/09/21/2300914/0/en/AllStar-Health-Shareholder-Update.html
Receive investor kits and email updates from Stockhouse and directly from these companies.
